Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma

被引：16
作者：
Cawood, T. J. [1 ]
Bridgman, P. [2 ]
Hunter, L. [3 ]
Cole, D. [1 ]
机构：
[1] Christchurch Hosp, Dept Endocrinol, Christchurch, New Zealand
[2] Christchurch Hosp, Dept Cardiol, Christchurch, New Zealand
[3] Christchurch Hosp, Dept Pathol, Christchurch, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2009年 / 39卷 / 04期
关键词：
DOPAMINE AGONISTS;
D O I：
10.1111/j.1445-5994.2009.01920.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：266 / 267
页数：2
相关论文
共 5 条
[1]   Focus on research - Drug and valvular heart disease [J].
Roth, Bryan L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :6-9
[2]   Dopamine agonists and the risk of cardiac-valve regurgitation [J].
Schade, Rene ;
Andersohn, Frank ;
Suissa, Samy ;
Haverkamp, Wilhelm ;
Garbe, Edeltraut .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :29-38
[3]   Dopamine agonist therapy and cardiac valve dysfunction [J].
Sherlock, Mark ;
Steeds, Richard ;
Toogood, Andy A. .
CLINICAL ENDOCRINOLOGY, 2007, 67 (05) :643-644
[4]  
Stephens JW, 2007, NEW ENGL J MED, V356, P1676
[5]   Valvular heart disease and the use of dopamine agonists for Parkinson's disease [J].
Zanettini, Renzo ;
Antonini, Angelo ;
Gatto, Gemma ;
Gentile, Rosa ;
Tesei, Silvana ;
Pezzoli, Gianni .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :39-46
1